A series of 2-substituted C-aryl glucosides have been synthesized and evaluated for inhibition of hSGLT1 and hSGLT2. Introduction of an appropriate ortho substituent at the proximal phenyl ring adjacent to the glycosidic bond was found to improve SGLT2 inhibitory activity and dramatically increase selectivity for hSGLT2 over hSGLT1. Selected compounds were investigated for in vivo efficacy.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmc.2010.04.088 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Circumventing glass vial and diluent effects on solution stability of small molecule analytes during analytical method development and validation.
J Pharm Biomed Anal
May 2022
Chemical Process Development, Global Product Development and Supply, Bristol Myers Squibb Company, New Brunswick, New Jersey, USA.
Solution stability of analytes plays an important part in qualitative analysis, especially in conducting accurate, quantitative analyses. Sample diluents and glass vials as sample containers for HPLC analyses can play a critical role and should be evaluated during chromatographic method development. We have encountered several instances during pharmaceutical development where the glass vial/diluent combination has negatively impacted method performance.
View Article and Find Full Text PDFDiscovery of GCC5694A: A potent and selective sodium glucose co-transporter 2 inhibitor for the treatment of type 2 diabetes.
Bioorg Med Chem Lett
January 2022
R&D Division, GC Pharma, Gyeonggi-do, Republic of Korea. Electronic address:
Sodium-dependent glucose co-transporter 2 (SGLT2) has emerged as a promising drug target for the treatment of type 2 diabetes, and recently, several SGLT2 inhibitors have been approved for clinical use. A series of molecules with a C-aryl glucoside scaffold was designed and synthesized for biological evaluation. Among the molecules tested, a dihydrobenzofuran-containing analog, 14g (GCC5694A), exhibited excellentin vitro activity against SGLT2 (IC = 0.
View Article and Find Full Text PDFNatural Products & Bioactivity Inspired Synthetic Pursuits Interfacing with Carbohydrates: Ongoing Journey with C-Glycosides.
Chem Rec
November 2021
Department of Chemistry, Indian Institute of Technology Madras, Chennai, 600036, India.
Natural products, remains the most important source for the discovery of new drugs for the treatment of human diseases. This has inspired the synthetic community to design and develop mimics of natural products either to answer important questions in biology or to explore their therapeutic potentials. Glycosides present themselves abundantly in nature, right from the cell surface receptors to natural products of any origin.
View Article and Find Full Text PDF5,5-Difluoro- and 5-Fluoro-5-methyl-hexose-based C-Glucosides as potent and orally bioavailable SGLT1 and SGLT2 dual inhibitors.
Bioorg Med Chem Lett
September 2020
Discovery Sciences and Metabolic Research, Janssen Research & Development, L.L.C., Welsh & McKean Roads, Spring House, PA 19477, United States.
(2S,3R,4R,5S,6R)-2-Aryl-5,5-difluoro-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diols and (2S,3R,4R,5S,6R)-2-aryl-5-fluoro-5-methyl-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4-diols were discovered as dual inhibitors of sodium glucose co-transporter proteins (e.g. SGLT1 and SGLT2) through rational drug design, efficient synthesis, and in vitro and in vivo evaluation.
View Article and Find Full Text PDFMetabolism and disposition of the SGLT2 inhibitor bexagliflozin in rats, monkeys and humans.
Xenobiotica
May 2020
Molecular Medicine Research Institute, Sunnyvale, CA, USA.
Article Synopsis
- - Bexagliflozin, an SGLT2 inhibitor, is metabolized in humans through oxidation and glucuronidation, primarily involving CYP3A4 and UGT1A9, leading to six key metabolites.
- - Human metabolism primarily produces glucuronide metabolites, and while rat metabolism favors oxidation, monkey metabolism closely parallels human metabolism, sharing all identified metabolites.
- - After ingesting bexagliflozin, the 3'-glucuronide is the main metabolite in circulation, contributing significantly to the drug's overall presence in the body, with a notable percentage recaptured in feces and urine.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!